Pegylated liposomal doxorubicin plus carboplatin in patients with metastatic breast cancer: a phase II study

Annals of Oncology ◽

10.1093/annonc/mds052 ◽

2012 ◽

Vol 23 (10) ◽

pp. 2599-2605 ◽

Author(s):

R.P. Collea ◽

F.W. Kruter ◽

J.E. Cantrell ◽

T.K. George ◽

S. Kruger ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Study ◽

Metastatic Breast ◽

Pegylated Liposomal Doxorubicin

Download Full-text

230 A Phase II Study of Pegylated Liposomal Doxorubicin Combined with Cyclophosphamide / 5-fluorouracil as Second Line Chemotherapy in Patients with Metastatic Breast Cancer Who Failed Previous Taxane-based Treatment

European Journal of Cancer ◽

10.1016/s0959-8049(12)70298-8 ◽

2012 ◽

Vol 48 ◽

pp. S109-S110

Author(s):

H.K. Chang ◽

Y.C. Lin ◽

K.M. Rau ◽

Y.Y. Chen ◽

K.D. Lee ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Study ◽

Metastatic Breast ◽

Pegylated Liposomal Doxorubicin ◽

Second Line ◽

Second Line Chemotherapy ◽

Line Chemotherapy

Download Full-text

Bi-weekly administration of pegylated liposomal doxorubicin plus paclitaxel in metastatic breast cancer (MBC) patients: A phase II study

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.844 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 844-844 ◽

Author(s):

E. Simoncini ◽

V. D. Ferrari ◽

V. Amoroso ◽

F. Valcamonico ◽

S. Grisanti ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Study ◽

Metastatic Breast ◽

Pegylated Liposomal Doxorubicin ◽

Weekly Administration

Download Full-text

Phase II Study of Bortezomib and Pegylated Liposomal Doxorubicin in the Treatment of Metastatic Breast Cancer

Clinical Breast Cancer ◽

10.3816/cbc.2010.n.061 ◽

2010 ◽

Vol 10 (6) ◽

pp. 465-470 ◽

Author(s):

William J. Irvin ◽

Robert Z. Orlowski ◽

Wing-Keung Chiu ◽

Lisa A. Carey ◽

Frances A. Collichio ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Study ◽

Metastatic Breast ◽

Pegylated Liposomal Doxorubicin

Download Full-text

A randomised phase II study of two different schedules of pegylated liposomal doxorubicin in metastatic breast cancer (EORTC-10993)

European Journal of Cancer ◽

10.1016/j.ejca.2005.12.011 ◽

2006 ◽

Vol 42 (7) ◽

pp. 882-887 ◽

Author(s):

R.E. Coleman ◽

L. Biganzoli ◽

P. Canney ◽

L. Dirix ◽

L. Mauriac ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Study ◽

Metastatic Breast ◽

Pegylated Liposomal Doxorubicin

Download Full-text

5075 POSTER Non-pegylated Liposomal Doxorubicin (Myocet e) Plus Docetaxel (Taxotere e) (MYTAX), as First-line Chemotherapy (CHT), in Metastatic Breast Cancer (MBC): Results of a Phase II Study

European Journal of Cancer ◽

10.1016/s0959-8049(11)71517-9 ◽

2011 ◽

Vol 47 ◽

pp. S353

Author(s):

L. Imperatori ◽

P. Lippe ◽

C. Trapuzzano ◽

G. Laid ◽

C. Cappelletti ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Study ◽

Metastatic Breast ◽

Pegylated Liposomal Doxorubicin ◽

Line Chemotherapy

Download Full-text

Pegylated liposomal doxorubicin (Lipo-Dox®) combined with cyclophosphamide and 5-fluorouracil is effective and safe as salvage chemotherapy in taxane-treated metastatic breast cancer: an open-label, multi-center, non-comparative phase II study

10.1186/s12885-015-1433-4 ◽

2015 ◽

Vol 15 (1) ◽

Author(s):

Kun-Ming Rau ◽

Yung-Chang Lin ◽

Yen-Yang Chen ◽

Jen-Shi Chen ◽

Kuan-Der Lee ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Study ◽

Metastatic Breast ◽

Pegylated Liposomal Doxorubicin ◽

Salvage Chemotherapy ◽

Download Full-text

Pegylated liposomal doxorubicin in combination with gemcitabine: a phase II study in anthracycline-naïve and anthracycline pretreated metastatic breast cancer patients

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-005-0116-2 ◽

2005 ◽

Vol 57 (5) ◽

pp. 615-623 ◽

Author(s):

Alessandra Fabi ◽

Gianluigi Ferretti ◽

Paola Papaldo ◽

Nello Salesi ◽

Mariangela Ciccarese ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Study ◽

Metastatic Breast ◽

Pegylated Liposomal Doxorubicin ◽

Breast Cancer Patients

Download Full-text

Phase II study of pegylated liposomal doxorubicin (PLD) and carboplatin (Cb) can be administered with trastuzumab (H) in patients with metastatic breast cancer.

10.1158/0008-5472.sabcs-6118 ◽

2009 ◽

Author(s):

RP Collea ◽

FW Kruter ◽

JE Cantrell ◽

TK George ◽

S Kruger ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Study ◽

Metastatic Breast ◽

Pegylated Liposomal Doxorubicin

Download Full-text

Pegylated liposomal doxorubicin (PLD) and gemcitabine (G) in metastatic breast cancer (MBC) patients: A phase II study

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.813 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 813-813 ◽

Author(s):

A. Fabi ◽

P. Papaldo ◽

M. Ciccarese ◽

N. Salesi ◽

V. Lorusso ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Study ◽

Metastatic Breast ◽

Pegylated Liposomal Doxorubicin

Download Full-text

Pegylated liposomal doxorubicin and gemcitabine in the front-line treatment of recurrent/metastatic breast cancer: a multicentre phase II study

British Journal of Cancer ◽

10.1038/sj.bjc.6604409 ◽

2008 ◽

Vol 98 (12) ◽

pp. 1916-1921 ◽

Author(s):

V Adamo ◽

V Lorusso ◽

R Rossello ◽

B Adamo ◽

G Ferraro ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Study ◽

Metastatic Breast ◽

Pegylated Liposomal Doxorubicin ◽

Line Treatment ◽

Multicentre Phase

Download Full-text